NCT07476404

Brief Summary

Project Summary: Retrospective Cohort Study

  1. 1.Core ObjectiveThe primary goal is to determine if the volume of Hydroxyethyl Starch (HES) 130/0.4 (specifically Voluven® or Volulyte®) administered during the removal of giant meningiomas (tumors \> 5 cm) increases the risk of postoperative complications.
  2. 2.Research Question
  3. 3.Outcomes Primary: Incidence of re-bleeding at the tumor bed requiring re-operation within 48 hours Secondary: New-onset postoperative AKI within 7 days (defined by KDIGO criteria)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2025

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 14, 2026

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

March 12, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 17, 2026

Completed
Last Updated

March 17, 2026

Status Verified

March 1, 2026

Enrollment Period

12 months

First QC Date

March 12, 2026

Last Update Submit

March 12, 2026

Conditions

Keywords

Re-bleeding after craniotomy to remove giant meningioma

Outcome Measures

Primary Outcomes (1)

  • The cumulative incidence of re-bleeding and required re-craniotomy within 48 hours

    The cumulative incidence of re-bleeding and required re-craniotomy within 48 hours

    7 days

Secondary Outcomes (1)

  • The incidence of new-onset postoperative Acute Kidney Injury (AKI)

    7 days

Study Arms (2)

Exposed Group

Patients who received HES during surgery

Other: exposure to Hydroxyethyl Starch (HES) Voluven® or Volulyte® 130/0.4

Non-Exposed Group

Patients who did not receive HES (received only crystalloids or other fluids).

Other: exposure to Hydroxyethyl Starch (HES) Voluven® or Volulyte® 130/0.4

Interventions

did and did not receive HES (received only crystalloids or other fluids)

Exposed GroupNon-Exposed Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients diagnosed of giant meningiomas, diameter of at least 5 cm. They were scheduling for craniotomy during 2016-2024. Withdrawal Criteria: There are no specific withdrawal criteria listed for this study. Ethical Consideration: Since this is a retrospective study using existing hospital electronic records, individual informed consent is not required.

You may qualify if:

  • Diagnosis: Patients must be diagnosed with a meningioma. Tumor Size: The tumor must be classified as "giant," defined as having a diameter of 5 cm or larger as seen on a CT scan.
  • Surgery Type: Patients must have undergone a craniotomy to remove the tumor. Timeframe: The surgery must have occurred between the years 2016 and 2024

You may not qualify if:

  • Recurrent Cases: Patients with a recurrent meningioma (rather than a first-time surgery).
  • Emergency Cases: Patients requiring an emergency craniotomy. Pregnancy: Any patient who is pregnant. Major Complications: Patients who experienced cardiac arrest during the surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chiang Mai University

Chiang Mai, 50200, Thailand

Location

Related Publications (13)

  • Vahdat S. A review of pathophysiological mechanism, diagnosis, and treatment of thrombosis risk associated with COVID-19 infection. Int J Cardiol Heart Vasc. 2022 Aug;41:101068. doi: 10.1016/j.ijcha.2022.101068. Epub 2022 Jun 3.

  • Beltrame JF, Tavella R, Zeitz CJ. Beyond Structural Angiography: The Emergence of Functional Coronary Angiography. J Am Coll Cardiol. 2022 Jun 21;79(24):2379-2382. doi: 10.1016/j.jacc.2022.04.014. No abstract available.

  • Podcast: Enigmatic neutron stars may soon give up their secrets. Nature. 2020 Jun 15. doi: 10.1038/d41586-020-01424-3. Online ahead of print. No abstract available.

  • Bonnesen B, Sivapalan P, Jordan A, Pedersen JW, Bergsoe CM, Eklof J, Toennesen LL, Jensen SG, Naqibullah M, Saghir Z, Jensen JS. Risk of Malignancy in Patients with Asthma-COPD Overlap Compared to Patients with COPD without Asthma. Biomedicines. 2022 Jun 21;10(7):1463. doi: 10.3390/biomedicines10071463.

  • Shanmugam S. Inverse Electrode Placement May Help to Improve Electrotherapeutic Effects in the Field of Chronic Pain Management. Korean J Pain. 2016 Jul;29(3):202-4. doi: 10.3344/kjp.2016.29.3.202. Epub 2016 Jul 1. No abstract available.

  • Disseldorp DJ, Poeze M, Hannemann PF, Brink PR. Is Bone Grafting Necessary in the Treatment of Malunited Distal Radius Fractures? J Wrist Surg. 2015 Aug;4(3):207-13. doi: 10.1055/s-0035-1558831.

  • Slawin J, Kubler P, Szczepanski A, Piatek J, Stepkowski M, Reczuch K. Radial artery occlusion after percutaneous coronary interventions - an underestimated issue. Postepy Kardiol Interwencyjnej. 2013;9(4):353-61. doi: 10.5114/pwki.2013.38865. Epub 2013 Nov 18.

  • Zhu Z, Liang Z, Liany H, Yang C, Wen L, Lin Z, Sheng Y, Lin Y, Ye L, Cheng Y, Chang Y, Liu L, Yang L, Shi Y, Shen C, Zhou F, Zheng X, Zhu J, Liang B, Ding Y, Zhou Y, Yin X, Tang H, Zuo X, Sun L, Bei JX, Liu J, Yang S, Yang W, Cui Y, Zhang X. Discovery of a novel genetic susceptibility locus on X chromosome for systemic lupus erythematosus. Arthritis Res Ther. 2015 Dec 3;17:349. doi: 10.1186/s13075-015-0857-1.

  • Varughese AM, Nick TG, Gunter J, Wang Y, Kurth CD. Factors predictive of poor behavioral compliance during inhaled induction in children. Anesth Analg. 2008 Aug;107(2):413-21. doi: 10.1213/ane.0b013e31817e616b.

  • Gruber EM, Laussen PC, Casta A, Zimmerman AA, Zurakowski D, Reid R, Odegard KC, Chakravorti S, Davis PJ, McGowan FX Jr, Hickey PR, Hansen DD. Stress response in infants undergoing cardiac surgery: a randomized study of fentanyl bolus, fentanyl infusion, and fentanyl-midazolam infusion. Anesth Analg. 2001 Apr;92(4):882-90. doi: 10.1097/00000539-200104000-00016.

  • Elgellab A, Riou Y, Abbazine A, Truffert P, Matran R, Lequien P, Storme L. Effects of nasal continuous positive airway pressure (NCPAP) on breathing pattern in spontaneously breathing premature newborn infants. Intensive Care Med. 2001 Nov;27(11):1782-7. doi: 10.1007/s00134-001-1117-1. Epub 2001 Oct 31.

  • Hayek SM, Fattouh M, Dews T, Kapural L, Malak O, Mekhail N. Successful treatment of spontaneous cerebrospinal fluid leak headache with fluoroscopically guided epidural blood patch: a report of four cases. Pain Med. 2003 Dec;4(4):373-8. doi: 10.1111/j.1526-4637.2003.03037.x.

  • Young KW, Greenwood CE, van Reekum R, Binns MA. A randomized, crossover trial of high-carbohydrate foods in nursing home residents with Alzheimer's disease: associations among intervention response, body mass index, and behavioral and cognitive function. J Gerontol A Biol Sci Med Sci. 2005 Aug;60(8):1039-45. doi: 10.1093/gerona/60.8.1039.

MeSH Terms

Conditions

Meningioma

Interventions

HES 130-0.4

Condition Hierarchy (Ancestors)

Neoplasms, Nerve TissueNeoplasms by Histologic TypeNeoplasmsNeoplasms, Vascular TissueMeningeal NeoplasmsCentral Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteNervous System Diseases

Study Officials

  • Pathomporn Pin on

    Chiang Mai University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
7 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 12, 2026

First Posted

March 17, 2026

Study Start

March 1, 2025

Primary Completion

February 14, 2026

Study Completion

March 1, 2026

Last Updated

March 17, 2026

Record last verified: 2026-03

Locations